Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice

Journal of Neuroscience Research

Volumn 82, Issue 3, 2005, Pages 357-367

  Wu, Min ^a   Wallace, Margaret R ^a,b   Muir, David ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Gene transfer; Neurofibroma; Neurofibromatosis type 1; Nf1 knockout; Schwann cell; Tumor model

Indexed keywords

GROWTH FACTOR; NEUROFIBROMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MODEL; FEMALE; HETEROZYGOSITY; KNOCKOUT MOUSE; MALE; MOUSE; NERVE GRAFT; NEUROFIBROMATOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; WILD TYPE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; SCHWANN CELLS; SCIATIC NERVE; TISSUE TRANSPLANTATION;

EID: 27644524672     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20646     Document Type: Article

References (40)

1. Arbiser JL, Flynn E, Barnhill RL. 1998. Analysis of vascularity of human neurofibromas. J Am Acad Dermatol 38:950-954.
2. Bajenaru ML, Donahoe J, Corral T, Reilly KM, Brophy S, Pellicer A, Gutmann DH. 2001. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 33:314-323.
3. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F. 1990. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851-859.
4. Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, Jeggo PA. 1996. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the seid mouse. Proc Natl Acad Sci U S A 93:10285-10290.
5. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8:1019-1029.
6. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176.
7. Colman SD, Williams CA, Wallace MR. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92.
8. Dong Z, Sinanan A, Parkinson D, Parmantier E, Mirsky R, Jessen KR. 1999. Schwann cell development in embryonic mouse nerves. J Neurosci Res 56:334-348.
9. Erlandson RA, Woodruff JM. 1982. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 49:273-287.
10. Ferguson TA, Muir D. 2000. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16:157-167.
11. Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A. 1999. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18:4450-4459.
12. Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW. 2000. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181-188.
13. Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA, Clapp DW. 2001. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 194:57-69.
14. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353-361.
15. Kamata Y. 1978. Study on the ultrastructure and acetylcholinesterase activity in von Recklinghausen's neurofibromatosis. Acta Pathol Jpn 28:393-410.
16. Kawachi Y, Xu X, Ichikawa E, Imakado S, Otsuka F. 2003. Expression of angiogenic factors in neurofibromas. Exp Dermatol 12:412-417.
17. Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE. 1995. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11:325-335.
18. Kim HA, Ling B, Ratner N. 1997. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol Cell Biol 17:862-872.
19. Kim HA, Ratner N, Roberts TM, Stiles CD. 2001. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. J Neurosci 21:1110-1116.
20. Kleihues P, Cavenee WK. 2000. Pathology and genetics of tumors of the nervous system. Lyon, France: IARC Press.
21. Knudson AG. 2000. Chasing the cancer demon. Annu Rev Genet 34:1-19.
22. Korf BR. 1999. Plexiform neurofibromas. Am J Med Genet 89:31-37.
23. Mashour GA, Wang HL, Cabal-Manzano R, Wellstein A, Martuza RL, Kurtz A. 1999. Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. J Invest Dermatol 113:398-402.
24. Muir D. 1994. Metalloproteinase-dependent neunte outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210:243-252.
25. Muir D. 1995. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metast 13:303-314.
26. Muir D, Varon S, Manthorpe M. 1990. Schwann cell proliferation in vitro is under negative autocrine control. J Cell Biol 111:2663-2671.
27. Muir D, Johnson J, Rojiani M, Inglis BA, Rojiani A, Maria BL. 1996. Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord. J Neurooncol 30:199-211.
28. Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR. 2001. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol 158:501-513.
29. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J. 1988. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760-771.
30. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, Rojiani AM, Maria BL, Muir D, Wallace MR. 2000. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 28:425-431.
31. Riccardi VM. 1992. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press.
32. Rizvi TA, Huang Y, Sidani A, Atit R, Largaespada DA, Boissy RE, Ratner N. 2002. A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J Neurosci 22:9831-9840.
33. Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E. 2000. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 9:1059-1066.
34. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lazaro C. 2000. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 9:3055-3064.
35. Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas NS, Potts C, Griffiths S, Ruggieri M, von Deimling A, Cooper DN. 2004. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23:134-146.
36. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF. 1999. Mouse tumor model for neurofibromatosis type 1. Science 286:2176-2179.
37. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.
38. +/- mast cells. J Clin Invest 112:1851-1861.
39. Zhang Y, Taylor BR, Shannon K, Clapp DW. 2001. Quantitative effects of NfI inactivation on in vivo hematopoiesis. J Clin Invest 108:709-715.
40. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. 2002. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920-922.